Timothy T. Goodnow Ph.d.
Chief Executive Officer, President and Director
Diabetes
Senseonics Holdings, Inc.
United States of America
Biography
Dr. Timothy T. Goodnow, also known as Tim, Ph.D., has been the Chief Executive Officer, President and Director of Senseonics Holdings, Inc. since December 2015. Dr. Goodnow served as the Chief Executive Officer and President of Senseonics, Inc.(also known as Sensors for Medicine and Science, Inc). since March 2011 until December 2015 and its Director since December 2010 until December 2015. Dr. Goodnow served as the Vice President of Research and Development at Abbott Diabetes Care, Inc. (alternate name, Therasense Inc.) since November 2000 and served as its Vice President of Technical Operations. From June 1999 to October 2000, Dr. Goodnow served a Vice President of Research and Development for Verax Biomedical Incorporated, a blood safety start-up company. From July 1998 to June 1999, Dr. Goodnow served in the capacity of Vice President of Research and Development for ZymeQuest, Inc., a start-up company specializing in the development of enzymic blood conversion processing systems for use in blood transfusion medicine. From January 1983 to July 1998, he served in various positions of increasing responsibility, including Vice President of Research and Development for Baxter Healthcare/Dade Behring, a global corporation providing products and support services to clinical laboratories. He has been a Director of Sensors for Medicine and Science, Inc. since November 8, 2010. Dr. Goodnow holds a B.S. and Ph.D. in Chemistry from the University of Miami.
Research Interest
Diabetes